AI assistant
Sending…
XBiotech Inc. — Director's Dealing 2021
Nov 23, 2021
34229_dirs_2021-11-23_97c65ebf-daa4-4a8c-8394-652958e1e21e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: XBiotech Inc. (XBIT)
CIK: 0001626878
Period of Report: 2021-11-19
Reporting Person: HAN QUEENA (VP Finance & HR)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-11-19 | Stock Option | $12.67 | A | 35000 | Acquired | 2031-11-19 | Common Stock (35000) | Direct |
More from XBiotech Inc.
Interim / Quarterly Report
2026
May 14
Annual Report
2026
Apr 29
Major Shareholding Notification
2026
Jan 23
Major Shareholding Notification
2026
Jan 23
Regulatory Filings
2025
Dec 9
Interim / Quarterly Report
2025
Nov 12
Director's Dealing
2025
Nov 12
Director's Dealing
2025
Nov 12
Director's Dealing
2025
Nov 12
Director's Dealing
2025
Nov 12